NovaBridge Biosciences
NASDAQ:NBP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
NovaBridge Biosciences
NASDAQ:NBP
|
US |
|
C
|
Charter Communications Inc
F:CQD
|
US |
|
Mediobanca Banca di Credito Finanziario SpA
F:ME90
|
IT |
|
N
|
Nov Inc
SWB:NO8
|
US |
|
E
|
East Japan Railway Co
F:EJR0
|
JP |
|
A
|
Aurubis AG
XMUN:NDA
|
DE |
|
Amalgamated Financial Corp
NASDAQ:AMAL
|
US |
|
Graphic Packaging Holding Co
NYSE:GPK
|
US |
|
L
|
Lloyds Banking Group PLC
XETRA:LLD
|
UK |
|
S
|
State Street Corp
SWB:ZYA
|
US |
|
C
|
Chorus Ltd
SWB:7CH
|
NZ |
|
Thungela Resources Ltd
LSE:TGA
|
ZA |
|
V
|
Volkswagen AG
F:VOW
|
DE |
|
Promotora y Operadora de Infraestructura SAB de CV
BMV:PINFRAL
|
MX |
|
W
|
Weichai Power Co Ltd
F:WI4
|
CN |
|
Mon Courtier Energie SAS
F:O4Z
|
FR |
|
S
|
Sands China Ltd
XMUN:599A
|
MO |
|
Mastercard Inc
NYSE:MA
|
US |
Bankruptcy Probability
NovaBridge Biosciences's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
NovaBridge Biosciences Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
NovaBridge Biosciences
NASDAQ:NBP
|
183.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
462.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
206.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
180.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
131.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
83.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
58.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
49.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
NovaBridge Biosciences's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, NovaBridge Biosciences has no debt.
You can find a full breakdown on its Balance Sheet.